DUTKO WORLDWIDE, LLC for BIOGENIDEC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | 2008). |
Medicare/Medicaid MMM
Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | US Sen. Spec. Cmte on Aging (2004-2008). |
Copyright/Patent/Trademark CPT
Monitoring federal legislation related to Patent Reform Act of 2007 (HR1908/S1145) and other health care issues and advise client as it affects them.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | US Sen. Spec. Cmte on Aging (2004-2008). |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.